DAVID KUBAN: Open Payments
NPI 1821027319 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 22 payments from 15 companies in 2025. Trend: 2023 $1,128 · 2024 $554 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Exact Sciences Corporation | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Eisai Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $26 |
| Viatris Specialty LLC | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: ZEPBOUND, JARDIANCE, The Cologuard Plus Collection Kit, REXULTI, Kerendia, AIRSUPRA, Leqembi, VRAYLAR.
Industry payments across TX — which companies pay providers there.
